e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Tobacco smoking and respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smoking and cultural properties of the main causative agents of infectious bacterial lung pathology
A. S. Sprykov, V. V. Shkaryn (Nizhny Novgorod, Russia)
Source:
Annual Congress 2004 - Tobacco smoking and respiratory disease
Session:
Tobacco smoking and respiratory disease
Session type:
Thematic Poster Session
Number:
1003
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. S. Sprykov, V. V. Shkaryn (Nizhny Novgorod, Russia). Smoking and cultural properties of the main causative agents of infectious bacterial lung pathology. Eur Respir J 2004; 24: Suppl. 48, 1003
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Characterization of the aetiological agent in patients with lung tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 11s
Year: 2006
Incidence of different pathogenic microorganisms and antibiotic susceptibility in a respiratory diseases unit
Source: Eur Respir J 2004; 24: Suppl. 48, 638s
Year: 2004
The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012
Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014
Opportunist mycobacterial lung disease - which drug combination is more effective?
Source: Breathe 2009; 6: 67-69
Year: 2009
Impact of cigarette smoke exposure on host–bacterial pathogen interactions
Source: Eur Respir J 2012; 39: 467-477
Year: 2012
A pathogen in patients with underlying lung disease: corynebacterium pseudodiphtericum
Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens
Year: 2008
The role of respiratory viruses in etiological structure of exacerbation of chronic and recurrent lung diseases in children
Source: Eur Respir J 2007; 30: Suppl. 51, 391s
Year: 2007
Association between clinical profile and etiologic agent of pneumonia
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Impact of HIV infection and smoking on lung immunity and related disorders
Source: Eur Respir J 2015; 46: 1781-1795
Year: 2015
Characterization of the aetiological agent in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006
The peculiarity of etiological agents of community-acquired pneumonia depends on the severity
Source: Eur Respir J 2006; 28: Suppl. 50, 2s
Year: 2006
Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020
Early interventions with bacterial metabolites to prevent the development of chronic lung diseases
Source: International Congress 2018 – Cross-talk in the lung microenvironment: implications for chronic lung disease
Year: 2018
The role of bacteria and viruses in lung disease
Source: International Congress 2016 – Diseases and defences of the respiratory mucosa
Year: 2016
Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020
Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms
Source: Eur Respir J 2007; 29: 793-803
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept